Results 251 to 260 of about 131,610 (332)
Balancing Promise and Peril: Hemophilia Gene Therapy Insights. [PDF]
Akula S +4 more
europepmc +1 more source
Nonviral neo‐nucleocapsids developed from a repurposed bacterial protein cage, and macrocyclic peptide pharmacophores via protein‐protein ligation, bacteria‐based directed evolution, lasso‐grafting, and mammalian cell‐based directed evolution enabled cell specific RNA delivery.
Daiki Kanayama +4 more
wiley +2 more sources
Lyophilization of Adeno-Associated Virus Serotypes for Storage and Global Distribution. [PDF]
McGlinch EB +3 more
europepmc +1 more source
Objective Myotonic dystrophy type 1 (DM1) is a highly variable, multisystemic genetic disorder caused by a CTG repeat expansion in the 3′ untranslated region of DMPK. Toxicity is exerted by repeat‐containing DMPK transcripts that sequester muscleblind‐like (MBNL) proteins and lead to deleterious yet predictable changes in alternative splicing.
Samuel T. Carrell +3 more
wiley +1 more source
Combine mitochondrial-targeted gene therapy and chemotherapy to treat triple-negative breast cancer. [PDF]
Varadkar T +8 more
europepmc +1 more source
Objective Biomarkers with clear contexts of use are important tools for amyotrophic lateral sclerosis (ALS) therapy development. Understanding their longitudinal trajectory in the untreated state is key to their use as potential markers of pharmacodynamic response.
Oleksandr Dergai +16 more
wiley +1 more source
Biomarkers Detecting the Activity of ANCA-Associated Vasculitis: A Systematic Literature Review. [PDF]
Baas L +6 more
europepmc +1 more source
Decreased scleral Wnt5a<sup>hi</sup> fibroblasts exacerbate myopia progression by disrupting extracellular matrix homeostasis in mice. [PDF]
Zhu H +14 more
europepmc +1 more source
Harnessing whole human liver ex situ normothermic perfusion for preclinical AAV vector evaluation [PDF]
Marti Cabanes‐Creus +20 more
openalex +1 more source

